(lp0
S'Why Is United Therapeutics  Down 5.6% Since the Last Earnings Report? Nasdaq - Mar 28, 2017 It has been about a month since the last earnings report for United Therapeutics Corporation UTHR . Shares have lost about 5.6% in that time frame, underperforming the market.Institutions Attracted to This Stock; Holding Majority of Shares: United ... - Midway MonitorCan United Therapeutics Corporation  Hit 229? - Aiken Advocate'
p1
aS'United Therapeutics Corporation  Receives An Update From Brokers The De Soto Edge - Jan 17, 2017 03/17/2017 - United Therapeutics Corporation had its  rating reiterated by analysts at Jefferies. They now have a USD 116 price target on the stock.'
p2
aS'United Therapeutics Corporation To Present At Barclays Global Healthcare ... PR Newswire  - Mar 7, 2017 SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., March 7, 2017 /PRNewswire/ -- United Therapeutics Corporation  announced today that Martine Rothblatt, Ph.UPDATE: Jefferies Downgrades United Therapeutics Corp.  to Underperform - StreetInsider.comUnited Therapeutics Co. - Receive News &amp; Ratings Daily - Chaffey Breeze'
p3
aS'Credit Suisse negative on United Therapeutics; shares slip 4% Seeking Alpha - Mar 16, 2017 United Therapeutics  goes south on modestly higher volume on the heels of an Underperform rating and $120  price target by Credit Suisse.'
p4
aS'Credit Suisse Starts United Therapeutics Corp.  at Underperform StreetInsider.com - Mar 16, 2017 Credit Suisse initiates coverage on United Therapeutics Corp.  with a Underperform rating and a price target of $120.00.United Therapeutics Corporation  Moves Lower on Volume Spike for March 16 - Equities.comAnalyst Activity  Credit Suisse Group AG Initiates Coverage On United ... - Market Exclusive'
p5
aS'Stock Volatility Risk Alert: United Therapeutics Corporation Realized ... CML News - 11 hours ago Before we cover the full analysis we make a quick alert here that United Therapeutics Corporation  has seen its stock price whip around at an elevated level.'
p6
aS"United Therapeutics Corporation To Present At Cowen And Company 37th Annual ... PR Newswire  - Feb 28, 2017 28, 2017 /PRNewswire/ -- United Therapeutics Corporation  announced today that Martine Rothblatt, Ph.D., Chairman and Chief Executive Officer of United Therapeutics, will provide an overview and update on the company's business at the&nbsp;..."
p7
aS'United Therapeutics Reaches Analyst Target Price Nasdaq - Mar 20, 2017 In recent trading, shares of United Therapeutics Corp  have crossed above the average analyst 12-month target price of $140.80, changing hands for $142.08/share.Quarterly EPS Forecast Of United Therapeutics Corporation  At $3.61 - RealistInvestor.comMartine A. Rothblatt Sells 1218 Shares of United Therapeutics Co.  Stock - Chaffey Breeze'
p8
aS"Northwell Health and United Therapeutics Announce Strategic Partnership to ... PR Newswire  - Mar 9, 2017 MANHASSET, N.Y. and SILVER SPRING, Md., March 9, 2017 /PRNewswire/ -- Northwell Health's Feinstein Institute for Medical Research and United Therapeutics Corporation  announced today a strategic partnership focused on the&nbsp;...Northwell, drug-maker ink bioelectronics partnership - Innovate Long Island"
p9
aS'Equity Insight: Indicator Review for United Therapeutics Corp  Midway Monitor - 9 hours ago Taking a look at the numbers, United Therapeutics Corp  has a 14-day Commodity Channel Index  of -51.19. The CCI technical indicator can be used to help determine if a stock is overbought or oversold.'
p10
a.